Regenerative Medicine Coalition
Research Areas
At a Glance
- Status: Completed Consortium
- Year Launched: 2012
- Initiating Organization: The Regenerative Medicine Coalition
- Initiator Type: Government
- No disease focus
- Location: International

Abstract
The Regenerative Medicine Coalition (RMC) is a working network aimed to accelerate the delivery of regenerative therapies to patients.
Mission
RMC works to share knowledge, infrastructure, and intellectual property and practice the principles of open innovation and jointly execute collaborative projects. RMC’s approach intends to accelerate cost-efficient therapy development.
Consortium History
January 2012: Consortium announced
Structure & Governance
There are three types of members in RMC: core, industry, and associate. Each membership level is associated with different benefits.
Executive Committee:
President, Chris Mason, London, UK
Vice president, Anthony Atala, Winston-Salem, N.C.
Secretary general, Frank-Roman Lauter, Berlin, Germany
Advisory Board:
Gregory A. Bonfiglio, Portola Valley, Calif. (chair)
Bernat Soria Escoms, Sevilla, Spain
Michael May, Toronto, Canada
Vinod Subramaniam, Eindhoven, The Netherlands
Rocky Tuan, Pittsburgh, Penn.
Christian van den Bos, Cologne, Germany
Hans-Dieter Volk, Berlin, Germany
Homepage |
|
|
https://www.linkedin.com/company/the-regenerative-medicine-coalition |
Points of Contact
Frank-Roman Lauter
Head of Business Development
Spokesman of the German-Californian RegMed Initiative
Secretary General & Co-Founder of The Regenerative Medicine Coalition
Berlin-Brandenburg Center for Regenerative Therapies
BCRT at Charité - Campus Virchow Clinic-
Augustenburger Platz 1
D-13353 Berlin
Germany
phone: +49 (0)30 - 450 539 413
fax: +49 (0)30 - 450 539 904
email: info@the-rmc.org
www.the-rmc.org
Sponsors & Partners
Advanced Centre for Biochemical Engineering, University College London |
Berlin-Brandenburg Center for Regenerative Therapies (BCRT) |
CABIMBER – Andalusian Center for Molecular Biology and Regenerative Medicine |
Center for Commercialization of Regenerative Medicine (CCRM), Toronto |
Charite – Universitatsmedizin Berlin |
Federal Ministry of Economics and Technology |
Federal Ministry of Education and Research |
Helmholtz Association |
Institute for Biomedical Technology and Technical Medicine University (MIRA) |
Johnson & Johnson |
Lonza Group |
McGowan Institute for Regenerative Medicine |
Newtorks of Centres of Excellence of Canada |
Proteus Regenerative Medicine |
Stifterverband fur die Deustche Wirtschaft |
Wake Forrest School of Medicine |